A First Time In Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK1399686

Clinical trial NCT00721812 · COMPLETED

Trial details

NCT number: NCT00721812
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Inflammatory Bowel Diseases

Start date: 2008-09-25
Primary completion: 2009-05-27
Enrollment: 87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.